The results showed that the expression of CD40L was increased significantly in myocardial tissues of the model group, while pre-treatment with BYHWD can significantly inhibit the expression of CD40L, suggesting that anti-inflammation by decreasing the CD40L expression is one of the potential mechanisms by which BYHWD protects myocardium from ischemia in rats. The gene discussed is CD40LG; the disease is ischemia.